NCT02299804View on ClinicalTrials.gov

A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

August 31, 2015

Conditions
Vertigo
Interventions
DRUG

Levophencynonate Hydrochloric

this drug is M receptor inhibitor

DRUG

Placebo

No active ingredient

Trial Locations (1)

200127

Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Sihuan Pharmaceutical Holdings Group Ltd.

INDUSTRY

NCT02299804 - A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo | Biotech Hunter | Biotech Hunter